UK Markets close in 5 hrs 18 mins
  • FTSE 100

    +50.44 (+0.70%)
  • FTSE 250

    +229.08 (+1.20%)
  • AIM

    +7.88 (+0.88%)

    -0.0003 (-0.03%)

    +0.0008 (+0.0614%)

    -44.28 (-0.25%)
  • CMC Crypto 200

    +13.85 (+3.05%)
  • S&P 500

    +116.01 (+3.06%)
  • DOW

    +823.28 (+2.68%)

    +0.28 (+0.26%)

    +9.80 (+0.54%)
  • NIKKEI 225

    +379.30 (+1.43%)

    +510.46 (+2.35%)
  • DAX

    +127.99 (+0.98%)
  • CAC 40

    +19.38 (+0.32%)

Insiders who bought in the last 12 months lose an additional UK£36k as ReNeuron Group plc (LON:RENE) drops to UK£17m

  • Oops!
    Something went wrong.
    Please try again later.
·3-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The recent 12% drop in ReNeuron Group plc's (LON:RENE) stock could come as a blow to insiders who purchased UK£49k worth of stock at an average buy price of UK£1.15 over the past 12 months. Insiders purchase with the hope of seeing their investments increase in value over time. However, due to recent losses, their initial investment is now only worth UK£13k, which is not great.

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.

Check out our latest analysis for ReNeuron Group

The Last 12 Months Of Insider Transactions At ReNeuron Group

Over the last year, we can see that the biggest insider purchase was by Senior Independent Non-Executive Director Barbara Staehelin for UK£49k worth of shares, at about UK£1.15 per share. So it's clear an insider wanted to buy, even at a higher price than the current share price (being UK£0.30). It's very possible they regret the purchase, but it's more likely they are bullish about the company. To us, it's very important to consider the price insiders pay for shares. As a general rule, we feel more positive about a stock when an insider has bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. The only individual insider to buy over the last year was Barbara Staehelin.

The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!


ReNeuron Group is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership of ReNeuron Group

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Our data indicates that ReNeuron Group insiders own about UK£2.1m worth of shares (which is 12% of the company). Whilst better than nothing, we're not overly impressed by these holdings.

So What Do The ReNeuron Group Insider Transactions Indicate?

There haven't been any insider transactions in the last three months -- that doesn't mean much. On a brighter note, the transactions over the last year are encouraging. The transactions are fine but it'd be more encouraging if ReNeuron Group insiders bought more shares in the company. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Be aware that ReNeuron Group is showing 3 warning signs in our investment analysis, and 1 of those shouldn't be ignored...

Of course ReNeuron Group may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting